GlassScriptPhysician profile
Ken Haberman
NPI 1225290489
$47,477.91
in general payments reported to CMS, 2019-2025
52 companies · $20K in 2025
The $20K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,603 · 2020: $199 · 2021: $656 · 2022: $856 · 2023: $12K · 2024: $12K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $38K · Food and Beverage: $4,650 · Travel and Lodging: $857 · Education: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $38,405.86 |
| Food and Beverage | $4,650.48 |
| Travel and Lodging | $857.17 |
| Education | $250.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verathon INC. | $38,405.86 | 2023-2025 | Npd Clinical Study, Video Laryngoscope |
| Procept Biorobotics Corporation | $1,078.13 | 2025 | |
| Astellas Pharma US INC | $967.43 | 2019-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $735.36 | 2019-2025 | Provenge |
| Janssen Biotech, INC. | $613.38 | 2019-2025 | Erleada, Akeega, Balversa |
| Myriad Genetic Laboratories, INC. | $474.70 | 2021-2024 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $392.26 | 2019-2024 | |
| Ferring Pharmaceuticals INC. | $322.67 | 2019-2025 | Adstiladrin |
| Abbvie INC. | $314.37 | 2019-2025 | |
| Coloplast Corp | $313.30 | 2019-2025 | |
| Boston Scientific Corporation | $293.11 | 2019-2023 | Advantage System |
| Pfizer INC. | $262.52 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $230.56 | 2022-2025 | Lynparza, Keytruda |
| Urogen Pharma, INC. | $214.83 | 2021-2025 | Jelmyto |
| Sumitomo Pharma America, INC. | $211.43 | 2023-2025 | Gemtesa, Orgovyx |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $210.62 | 2019-2025 | Xyosted |
| Progenics Pharmaceuticals, INC. | $149.86 | 2021-2025 | Pylarify |
| Myovant Sciences INC. | $147.83 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $146.57 | 2019-2025 | Bard Urinary Drainage Bag |
| Blue Earth Diagnostics | $119.96 | 2024-2025 | Posluma |
| Osiris Therapeutics INC. | $119.63 | 2019 | |
| Convatec INC. | $115.81 | 2024-2025 | |
| Endo USA, INC. | $114.78 | 2024-2025 | Xiaflex, Aveed |
| Astrazeneca Pharmaceuticals LP | $110.75 | 2021-2025 | Faslodex, Lynparza |
| Immunitybio, INC. | $110.65 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $109.52 | 2019-2023 | Xiaflex |
| Novartis Pharmaceuticals Corporation | $103.65 | 2023-2025 | |
| Allergan, INC. | $90.26 | 2019-2021 | |
| Urovant Sciences INC | $88.81 | 2021-2022 | |
| Accord Healthcare, INC. | $88.31 | 2023-2025 | |
| 180 Medical, INC. | $85.69 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $73.76 | 2019-2023 | Yonsa |
| Bluewind Medical | $72.83 | 2025 | Revi |
| Rochester Medical Corporation | $69.14 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $64.03 | 2021-2022 | |
| Smith+Nephew, INC. | $39.74 | 2022-2023 | Stravix |
| Therapeuticsmd, INC. | $36.60 | 2019-2020 | |
| Olympus America INC. | $35.46 | 2023-2025 | Itind System |
| Profound Medical Corp. | $31.56 | 2022-2025 | Tulsa-Pro |
| Teleflex LLC | $30.73 | 2025 | Deknatel |
| Angiodynamics, INC. | $30.35 | 2024 | Nanoknife |
| Telix Pharmaceuticals | $28.75 | 2023 | Illuccix |
| Tolmar, INC. | $27.88 | 2023 | |
| Ethicon US, LLC | $26.87 | 2021 | |
| Hollister Incorporated | $26.45 | 2022-2023 | Vapro Pocket |
| Baxter Healthcare | $25.43 | 2025 | Tisseel |
| Amgen INC. | $24.38 | 2019 | |
| Laborie Medical Technologies Corp. | $21.47 | 2023 | |
| Dentsply Ih INC. | $20.89 | 2020 | |
| Palette Life Sciences, INC. | $20.45 | 2023 | |
| Karl Storz Endoscopy-America | $18.45 | 2025 | N.A. |
| Amniox Medical, INC. | $10.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ken Haberman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.